Group Allows Sales to Poor Countries

FEBRUARY 01, 2006

Low-cost generic drugs to treat infectious diseases such as malaria, tuberculosis, and AIDS will be more widely available to underprivileged countries under a new World Trade Organization (WTO) accord supported by the United States. The United States is the first of the 149 governments in the WTO to formally accept the agreement, and US trade representative Rob Portman is encouraging other nations to endorse the deal.

"Our acceptance of this amendment is an important step in the global effort in providing the best access to lifesaving drugs,"Portman said. The accord will take effect no later than Dec. 1, 2007, if it receives final ratification by two thirds of the WTO membership.




SHARE THIS SHARE THIS
0

Become A RESPIMAT T.O.P. Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?


Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.